课题基金 / 基金详情

Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)

Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
赋权年轻科学家继续参与研究(CURE 是)
批准号:
10929573
负责人:
James A. DeCaprio
金额:
$20.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-19 至 2024-08-31

项目摘要

项目成果

James A. DeCaprio的其他基金

相似基金

相关文献

中文摘要
翻译
青年赋权科学家持续参与研究(YES for CURE) 增加代表性不足的少数群体参与和保留与癌症有关的 科学、技术、工程和数学(STEM)领域对于消除癌症差异至关重要 和改善美国的癌症预后。Dana-Farber/哈佛癌症中心(DF/HCC) 要求提供资金,以解决统一资源管理机制和社会经济弱势个人的短缺问题 癌症研究相关的职业。我们的具体目标是激发科学好奇心, 来自代表性不足的有前途的年轻科学家的学术成功和未来的研究事业 社区. 15年来,DF/HCC将高中生和大学生从 通过将他们置于真实的研究环境中, 哈佛大学附属癌症研究机构通过持续资助的P30 CURE 今年结束的补充。超过三分之二的校友继续完成STEM学位, 成功追求科学和健康相关的职业。我们建议继续并扩大这项工作 通过YES for CURE计划,该计划将提供多年的癌症和癌症差异研究 为波士顿地区的高中生和本科生提供经验和教育规划。 每年,40名来自波士顿地区的优秀高中生和大学生,通过竞争性的选拔, 申请过程中,将从事由三个相互关联的组件组成的程序:(1)指导,充分- 在DF/HCC癌症研究实验室的夏季研究经验;(2)全年创新策略, 科学成功课程侧重于培养科学和专业能力;(3)社区 家庭参与和外展,旨在发展一个支持性的,知情的,参与的 网络谁将培育和授权计划参与者实现学术成功和追求职业生涯 在科学研究中。这三个组成部分将交织在一起,成为一个全面的, 经验,将主要参与者进一步的学术培训和科学研究的职业生涯, 追求进一步的,程序独立的研究经验。此外,我们将利用我们广泛的学生 跟踪专业知识,以评估YES for CURE计划对学生兴趣和准备的影响 对于癌症和癌症的差距研究事业和他们的科学技能和概念的收购。 通过关注学生在他们的学术生涯的开始,我们预计,是治愈 该计划将激发和培养参与者对追求科学学位和癌症研究事业的兴趣 并增加癌症相关领域代表性不足的参与者的保留。
英文摘要
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE) Project Summary Increasing the participation and retention of underrepresented minorities (URMs) in cancer-related science, technology, engineering, and mathematics (STEM) fields is critical for eliminating cancer disparities and improving cancer outcomes in the United States. The Dana-Farber/Harvard Cancer Center (DF/HCC) requests funding to address the shortfall of URMs and socioeconomically disadvantaged individuals engaged in cancer research related careers. Our specific goal is to engage the scientific curiosity and promote the academic success and future research careers of promising young scientists from underrepresented communities. For over 15 years, DF/HCC has connected high school and college students from underrepresented populations to the world of cancer research by placing them in real research settings at Harvard University-affiliated cancer research institutions through a continuously funded P30 CURE Supplement ending this year. More than two thirds of our alumni have gone on to complete STEM degrees and to successfully pursue science and health-related careers. We propose to continue and expand this work through the YES for CURE Program, which will provide multi-year cancer and cancer disparities research experiences and educational programming for high school students and undergraduates in the Boston area. Each year, 40 talented high school and college students from the Boston area, selected through a competitive application process, will engage in a program comprised of three interrelated components: (1) mentored, full- time summer research experiences in DF/HCC cancer research labs; (2) a year-round innovative Strategies for Science Success curriculum focused on building scientific and professional competency; and (3) community and family engagement and outreach geared towards developing a supportive, informed, and engaged network who will nurture and empower program participants to achieve academic success and pursue careers in scientific research. These three components will be woven together into a comprehensive, multi-year experience that will prime participants for further academic training and careers in scientific research and the pursuit of further, program-independent research experiences. Further, we will leverage our extensive student tracking expertise to assess the impact of the YES for CURE Program on student interest in and preparation for cancer and cancer disparities research careers and their scientific skills and concepts acquisition. By focusing on students at the beginning of their academic career, we anticipate that the YES for CURE Program will spark and nurture participant interest in pursuing science degrees and cancer research careers and increase the retention of underrepresented participants in cancer-related fields.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Prevention of type 2 diabetes through remotely administered lifestyle programs: A systematic review.
通过远程管理的生活方式计划预防 2 型糖尿病:系统评价。
DOI: 10.1016/j.cct.2022.106817
发表时间: 2022
期刊: Contemporary clinical trials
影响因子: 2.2
作者: [Villegas,Valaree, Shah,Alisha, Manson,JoAnnE, Tobias,DeirdreK]
通讯作者: Tobias,DeirdreK
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
  • 批准号:
    10460971
  • 项目类别:
  • 资助金额:
    $101.45万
  • 财政年份:
    2019
  • 负责人:
    James A. DeCaprio
  • 依托单位:
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
  • 批准号:
    10411425
  • 项目类别:
  • 资助金额:
    $9.09万
  • 财政年份:
    2019
  • 负责人:
    James A. DeCaprio
  • 依托单位:
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
  • 批准号:
    10664906
  • 项目类别:
  • 资助金额:
    $101.45万
  • 财政年份:
    2019
  • 负责人:
    James A. DeCaprio
  • 依托单位:
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
  • 批准号:
    9816351
  • 项目类别:
  • 资助金额:
    $89.55万
  • 财政年份:
    2019
  • 负责人:
    James A. DeCaprio
  • 依托单位:
海外基金